0.00Open0.00Pre Close0 Volume0 Open Interest15.00Strike Price0.00Turnover165.91%IV-20.97%PremiumJan 17, 2025Expiry Date2.60Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7099Delta0.1009Gamma3.97Leverage Ratio-0.0578Theta-0.0029Rho-2.82Eff Leverage0.0070Vega
Indivior Stock Discussion
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...
No comment yet